Immune checkpoint inhibitor‐induced Type 1 diabetes: a systematic review and meta‐analysis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immune checkpoint inhibitor‐induced Type 1 diabetes: a systematic review and meta‐analysis
Authors
Keywords
-
Journal
DIABETIC MEDICINE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-06-14
DOI
10.1111/dme.14050
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adverse Events Associated With Immune Checkpoint Inhibitors
- (2019) Halis Kaan Akturk et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint Inhibitors
- (2018) Angeliki M. Stamatouli et al. DIABETES
- Programmed cell death-1 (PD-1) inhibitor induced type 1 diabetes mellitus: mini-review
- (2018) Katrien Clotman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Adverse Events Associated with Immune Checkpoint Blockade
- (2018) NEW ENGLAND JOURNAL OF MEDICINE
- Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
- (2018) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- PD-1 Inhibitor Immune-Related Adverse Events in Patients with Preexisting Endocrine Autoimmunity
- (2018) Halis Kaan Akturk et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Increased Reporting of Immune Checkpoint Inhibitor–Associated Diabetes
- (2018) Jordan J. Wright et al. DIABETES CARE
- Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2017) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reversing T-cell Dysfunction and Exhaustion in Cancer
- (2016) H. M. Zarour CLINICAL CANCER RESEARCH
- Anti–PD-1 and Anti–PDL-1 Monoclonal Antibodies Causing Type 1 Diabetes
- (2015) Mahnaz Mellati et al. DIABETES CARE
- Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future
- (2015) Lieping Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Additive and interaction effects at three amino acid positions in HLA-DQ and HLA-DR molecules drive type 1 diabetes risk
- (2015) Xinli Hu et al. NATURE GENETICS
- Releasing the Brakes on Cancer Immunotherapy
- (2015) Antoni Ribas NEW ENGLAND JOURNAL OF MEDICINE
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Type 1 diabetes
- (2013) Mark A Atkinson et al. LANCET
- Tumor Immunotherapy Directed at PD-1
- (2012) Antoni Ribas NEW ENGLAND JOURNAL OF MEDICINE
- Hyperglycemic Crises in Adult Patients With Diabetes
- (2009) A. E. Kitabchi et al. DIABETES CARE
- Clinical Applications of Diabetes Antibody Testing
- (2009) Polly J. Bingley JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Genetics of Type 1A Diabetes
- (2009) Patrick Concannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- HLA DR-DQ Haplotypes and Genotypes and Type 1 Diabetes Risk: Analysis of the Type 1 Diabetes Genetics Consortium Families
- (2008) H. Erlich et al. DIABETES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started